百合花(603823) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 568,678,551.27, a decrease of 3.60% compared to CNY 589,890,529.88 in the same period last year[4] - Net profit attributable to shareholders increased by 12.71% to CNY 45,788,834.25 from CNY 40,626,753.88 year-on-year[4] - The basic earnings per share rose by 10.00% to CNY 0.11, compared to CNY 0.10 in the previous year[5] - Operating profit for Q1 2025 was CNY 58,719,015.19, slightly up from CNY 58,212,536.99 in Q1 2024[17] - Net profit for Q1 2025 was CNY 60,833,307.19, compared to CNY 60,439,923.06 in Q1 2024, indicating a stable performance[17] - The net profit for Q1 2025 was CNY 50,198,940.12, an increase of 3.7% compared to CNY 48,298,461.87 in Q1 2024[18] - The net profit attributable to shareholders of the parent company was CNY 45,788,834.25, up 12.7% from CNY 40,626,753.88 in the previous year[18] - The total comprehensive income for Q1 2025 was CNY 50,198,940.12, reflecting a growth from CNY 48,298,461.87 in the previous year[18] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,388,546,268.78, a decrease of 1.71% from CNY 3,447,435,676.16 at the end of the previous year[5] - Total assets decreased to CNY 3,388,546,268.78 as of March 31, 2025, from CNY 3,447,435,676.16 as of December 31, 2024[14] - Total liabilities decreased to CNY 774,032,247.23 from CNY 879,070,594.73, indicating improved financial health[15] - The total liabilities decreased to CNY 480,398,155.23 in Q1 2025 from CNY 563,770,487.77 in Q1 2024, a reduction of 14.8%[26] - The total equity increased to CNY 2,214,817,575.32 in Q1 2025, up from CNY 2,165,855,586.56 in Q1 2024, reflecting a growth of 2.3%[26] Cash Flow - Cash flow from operating activities showed a significant improvement, with a net cash outflow of CNY -2,665,986.17 compared to CNY -12,525,945.50 in the same period last year[4][7] - The operating cash flow for Q1 2025 was CNY -2,665,986.17, an improvement from CNY -12,525,945.50 in Q1 2024[21] - The net cash flow from operating activities for Q1 2025 was negative CNY 2,109,930.52, compared to positive CNY 6,653,658.83 in Q1 2024[30] - The cash flow from investing activities for Q1 2025 was CNY -18,219,532.00, compared to CNY -52,630,270.26 in Q1 2024[22] - The company reported a decrease in investment activity cash flow, with a net cash flow of negative CNY 2,086,778.94 in Q1 2025 compared to negative CNY 9,417,347.83 in Q1 2024[31] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,295, indicating a stable shareholder base[9] - The largest shareholder, Baihehua Holdings Co., Ltd., holds 63.39% of the shares, with 263,941,361 shares pledged[10] Research and Development - Research and development expenses increased to CNY 19,194,556.80 in Q1 2025, up 32.5% from CNY 14,429,162.06 in Q1 2024[28] - The company plans to continue focusing on R&D to drive future growth, as indicated by the significant increase in R&D expenses[28]